MARKET

ATAI

ATAI

Atai Beckley Inc
NASDAQ
7.28
-0.11
-1.49%
After Hours: 7.30 +0.02 +0.27% 19:47 09/08 EDT
OPEN
7.32
PREV CLOSE
7.39
HIGH
7.40
LOW
7.23
VOLUME
119.76M
TURNOVER
--
52 WEEK HIGH
7.45
52 WEEK LOW
3.265
MARKET CAP
2.70B
P/E (TTM)
-3.3358
1D
5D
1M
3M
1Y
5Y
1D
After Hours Most Active for Sep 8, 2026 : ATAI, NU, RIG, NVDA, KO, T, AS, WMT, MRK, HBAN, ON, AAPL
NASDAQ · 9h ago
Lilly Builds Neuroscience into a New Long-Term Growth Driver
NASDAQ · 17h ago
Weekly Report: what happened at ATAI last week (0831-0904)?
Weekly Report · 1d ago
3 things to look out for on Tuesday
Seeking Alpha · 4d ago
Jim Cramer Isn't Sure If There’s Upside In This Health Care Stock
Benzinga · 5d ago
AtaiBeckley Says Hart-Scott-Rodino Waiting Period For Merger With Eli Lilly Expired On Aug 28, 2026; UK Competition Authority Has No Further Questions On Merger As Of August 21, 2026
Benzinga · 08/31 20:42
Weekly Report: what happened at ATAI last week (0824-0828)?
Weekly Report · 08/31 10:18
Press Release: AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
Dow Jones · 08/28 18:28
More
About ATAI
AtaiBeckley Inc is a clinical-stage biotechnology company focused on developing rapid-acting, durable and convenient mental health treatments. The Company’s pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 (R-MDMA HCI) for social anxiety disorder. The Company is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for opioid use disorder and TRD. BPL-003 is a proprietary synthetic intranasal formulation of mebufotenin benzoate being developed as a potential treatment for people living with TRD. VLS-01 is a proprietary oral transmucosal film formulation of N,N-Dimethyltryptamine (DMT) being developed as a potential treatment for people living with TRD. EMP-01 is an oral formulation of R-MDMA, being developed as a potential treatment for people living with social anxiety disorder.

Webull offers AtaiBeckley Inc stock information, including NASDAQ: ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.